Neonates born to mothers using antidepressant drugs.

[1]  Tram Nguyen,et al.  Antidepressants in Pregnancy: a Systematic Review , 2010, The Australian and New Zealand journal of psychiatry.

[2]  G. Zuccotti,et al.  Paroxetine and neonatal withdrawal syndrome , 2010, BMJ Case Reports.

[3]  B. Källén,et al.  Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data , 2010, Psychological Medicine.

[4]  Jennita Reefhuis,et al.  Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. , 2007, The New England journal of medicine.

[5]  B. Källén,et al.  Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. , 2007, Birth defects research. Part A, Clinical and molecular teratology.

[6]  S. Hernández-Díaz,et al.  Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn , 2006, The New England journal of medicine.

[7]  B. Vandermeer,et al.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis , 2006, BMJ : British Medical Journal.

[8]  M. Owens,et al.  Antidepressants in amniotic fluid: another route of fetal exposure. , 2006, The American journal of psychiatry.

[9]  O. Spigset,et al.  Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy , 2005, Drug safety.

[10]  O. Spigset,et al.  Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant. , 2005, Drug safety.

[11]  B. Källén.  Neonate characteristics after maternal use of antidepressants in late pregnancy. , 2004, Archives of pediatrics & adolescent medicine.

[12]  H. Flynn,et al.  Depressive symptoms among pregnant women screened in obstetrics settings. , 2003, Journal of women's health.